Ben Yong (CIK 1967669) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-15). Recent activity: Sell CRBP (2,000 shares), Sell BBOT (1,047 shares), Buy CRBP (3,800 shares), Sell BBOT (1,047 shares), Buy BBOT (46,670 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Sell | 2,000 | $15,683 |
| 2026-07-06 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Chief Med & Dev Officer | Sell | 1,047 | $8,167 |
| 2026-05-21 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Buy | 3,800 | $0 |
| 2026-05-05 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Chief Med & Dev Officer | Sell | 1,047 | $9,454 |
| 2026-03-12 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Chief Med & Dev Officer | Buy | 46,670 | $0 |
| 2025-06-02 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Buy | 4,800 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15